Regeneron Pharmaceuticals, Inc.

GUGGENHEIM CAPITAL LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

44,918

Value ($000)

34,671

Weight

0.3%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	34,671	0.3%	44,918	12/31/2025
2025 Q3	11/13/2025	23,789	0.2%	42,308	9/30/2025
2025 Q2	8/13/2025	21,122	0.2%	40,232	6/30/2025
2025 Q1	5/14/2025	20,971	0.2%	33,066	3/31/2025
2024 Q4	2/13/2025	26,793	0.2%	37,613	12/31/2024
2024 Q3	11/13/2024	40,330	0.3%	38,364	9/30/2024
2024 Q2	8/14/2024	45,817	0.3%	43,592	6/30/2024
2024 Q1	5/14/2024	39,802	0.3%	41,353	3/31/2024
2023 Q4	2/14/2024	37,717	0.3%	42,944	12/31/2023
2023 Q3	11/14/2023	32,541	0.3%	39,541	9/30/2023
2023 Q2	8/11/2023	27,756	0.2%	38,628	6/30/2023
2023 Q1	5/11/2023	34,481	0.3%	41,965	3/31/2023
2022 Q4	2/14/2023	36,112	0.3%	50,052	12/31/2022
2022 Q3	11/14/2022	37,554	0.3%	54,515	9/30/2022
2022 Q2	8/15/2022	37,071	0.3%	62,712	6/30/2022
2022 Q1	5/16/2022	46,649	0.3%	66,791	3/31/2022
2021 Q4	2/14/2022	49,029	0.3%	77,637	12/31/2021
2021 Q3	11/15/2021	42,649	0.3%	70,471	9/30/2021
2021 Q2	8/13/2021	44,372	0.3%	79,444	6/30/2021
2021 Q1	5/13/2021	32,220	0.2%	68,101	3/31/2021
2020 Q4	2/16/2021	31,475	0.2%	65,150	12/31/2020
2020 Q3	11/13/2020	36,509	0.3%	65,220	9/30/2020
2020 Q2	8/14/2020	43,469	0.3%	69,701	6/30/2020
2020 Q1	6/2/2020	36,778	0.4%	75,320	3/31/2020
2019 Q4	2/20/2020	33,606	0.3%	89,505	12/31/2019
2019 Q3	2/20/2020	24,633	0.2%	88,799	9/30/2019
2014 Q1	5/16/2014	91,599	0.3%	305,044	3/31/2014
2013 Q4	2/14/2014	58,764	0.2%	213,500	12/31/2013